Monovisc is a single injection viscosupplement suited for treatment of the joint pain caused by osteoarthritis. In cases of osteoarthritis, the amount of natural hyaluronan is reduced and the quality may be poorer than normal, which causes irritation and inflammation, pain and stiffness in the joints. Monovisc is a gel substance that consists of the maximum dose of HA (88mg). The product adds HA to the joint when injected, where it acts as a lubricant and pain reliever.
Monovisc is given in a shot (injection) directly into the knee joint.
The pack consists of:
Composition of the product:
- Partially cross-linked sodium Hyaluronate (NaHA)
- 88 mg Hyaluronan
- 36 mg Sodium Chloride
Benefits of Monovisc 4ml:
How long does the result last for?
Monovisc can provide up to 6 months of pain relief. The results may vary individually, some people feel relief immediately after their injection.
THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)
Anika Therapeutics is a global medical tech company that offers wound healing, pain management and tissue regeneration. They develop innovative medical solutions in order to help patients remain active in a safe and natural way. Anika Therapeutics is a manufactory that distributes a wide range of hyaluronic acid (HA) products specialized in therapeutic applications. HA is a natural component of the body that is vital to healthy tissue function. The brand only collaborates with industry leaders that deliver the newest therapeutic and advanced healthcare.